Skip to content

Enum: ClinicalTrialPhaseEnum

Clinical trial phase categories per FDA/NIH standards

URI: dismech:enum/ClinicalTrialPhaseEnum

Permissible Values

Value Meaning Description
PHASE_I None Phase I - Initial safety and dosage assessment in small group (20-100 partici...
PHASE_II None Phase II - Efficacy and side effects assessment in larger group (100-500 part...
PHASE_III None Phase III - Efficacy confirmation and monitoring in large population (1000-50...
PHASE_IV None Phase IV - Post-market surveillance and additional benefits/risks studies
NOT_APPLICABLE None Trial does not follow standard FDA phase classification (e

Slots

Name Description
phase Trial phase

Identifier and Mapping Information

Schema Source

  • from schema: https://w3id.org/monarch-initiative/dismech

LinkML Source

name: ClinicalTrialPhaseEnum
description: Clinical trial phase categories per FDA/NIH standards
from_schema: https://w3id.org/monarch-initiative/dismech
rank: 1000
permissible_values:
  PHASE_I:
    text: PHASE_I
    description: Phase I - Initial safety and dosage assessment in small group (20-100
      participants)
  PHASE_II:
    text: PHASE_II
    description: Phase II - Efficacy and side effects assessment in larger group (100-500
      participants)
  PHASE_III:
    text: PHASE_III
    description: Phase III - Efficacy confirmation and monitoring in large population
      (1000-5000 participants)
  PHASE_IV:
    text: PHASE_IV
    description: Phase IV - Post-market surveillance and additional benefits/risks
      studies
  NOT_APPLICABLE:
    text: NOT_APPLICABLE
    description: Trial does not follow standard FDA phase classification (e.g., observational,
      device studies)